investor mdsol.com

Investor Relations Medidata Solutions, Inc.

The Investor Relations website contains information about Medidata Solutions, Inc.s business for stockholders, potential investors, and financial analysts.

OVERVIEW

The site investor.mdsol.com currently has a traffic ranking of zero (the lower the superior). We have inspected nineteen pages within the site investor.mdsol.com and found twenty websites referring to investor.mdsol.com. We were able to detect four social media accounts retained by investor.mdsol.com.
Pages Crawled
19
Links to this site
20
Social Links
4

INVESTOR.MDSOL.COM TRAFFIC

The site investor.mdsol.com has seen a alternation levels of traffic for the duration of the year.
Traffic for investor.mdsol.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.mdsol.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.mdsol.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO DOMAIN

Medidata Solutions Saas-based Clinical Development Solutions

Randomization and Trial Supply Management. Advanced applications and analytics for clinical development.

WHAT DOES INVESTOR.MDSOL.COM LOOK LIKE?

Desktop Screenshot of investor.mdsol.com Mobile Screenshot of investor.mdsol.com Tablet Screenshot of investor.mdsol.com

INVESTOR.MDSOL.COM SERVER

We discovered that the main page on investor.mdsol.com took three hundred and sixty-four milliseconds to load. Our crawlers could not observe a SSL certificate, so our crawlers consider investor.mdsol.com not secure.
Load time
0.364 secs
SSL
NOT SECURE
Internet Protocol
23.55.218.214

BROWSER ICON

SERVER OS

We discovered that this website is weilding the nginx server.

HTML TITLE

Investor Relations Medidata Solutions, Inc.

DESCRIPTION

The Investor Relations website contains information about Medidata Solutions, Inc.s business for stockholders, potential investors, and financial analysts.

PARSED CONTENT

The site investor.mdsol.com states the following, "Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives." We observed that the website said " How Do Technology and Data Accelerate Precision Medicine in Oncology? Industry Experts to Discuss During Medidata Webinar." It also stated " How may we help you?."

SEEK MORE WEBSITES

MedImmune Investors Investor Relations Home

MedImmune is part of the AstraZeneca group of companies. Please direct all investor relations inquiries to AstraZeneca. Maryland Regional Biotech Forum Aims to Propel Washington, D. Metro Region to a Top Three Ranked U. MedImmune Presents Promising New Data in Systemic Lupus at American College of Rheumatology Meeting.

Investor Relations Mercadolibre, Inc.

Mercado Libre - Donde comprás y vendés de todo. Reports Fourth Quarter and Full Year 2017 Financial Results. to Report Fourth Quarter 2017 Financial Results. Reports Third Quarter Financial Results. 742 million Sold Items, up 55. 3 million Total Payment Transactions, up 69.

Mercury Insurance Save money on your auto insurance and more with Mercury

Low Rates and Incredible Service. Get a Fast, Free Quote. Low Rates and Incredible Service. Get an auto insurance quote and buy your policy online. Find an Agent Near You. Let a Mercury agent do the work for you. Just enter your zip code or browse agents by state.

Meridian Bank - Investor Information

Equal Housing Lender â Member FDIC.

Meridian Bioscience, Inc - Investor Relations -Investor Overview

Board of Directors and Management. Ask for our annual reports or more information. Sign up for email alerts. Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance.